Add Company
Join Now

Fleming Pharmaceuticals Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Fleming Pharmaceuticals's estimated annual revenue is currently $9.6M per year.(i)
  • Fleming Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Fleming Pharmaceuticals has 48 Employees.(i)
  • Fleming Pharmaceuticals grew their employee count by 0% last year.

Fleming Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2591.1M80577%N/AN/A
#2
$13.1M655%N/AN/A
#3
$9.6M48-29%N/AN/A
#4
$12.5M629%N/AN/A
#5
$43.8M2184%N/AN/A
#6
$1.8M1864%N/AN/A
#7
$6.6M33-3%N/AN/A
#8
$11.7M5812%N/AN/A
#9
$1104.4M34340%$97MN/A
#10
$21.3M1067%N/AN/A
Add Company

What Is Fleming Pharmaceuticals?

Specializing in the development and manufacture of innovative prescription and over-the-counter (OTC) therapies, privately held Fleming Pharmaceuticals is the proud maker of MAGONATE®, NEPHROCAPS®, NEPHROCAPS® QT, ThyroShield®, ProBarimin QT® and the OCEAN® Nasal Care line of products. Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology. Based in the greater St. Louis area, our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$9.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.8M487%N/A
#2
$8.9M494%N/A
#3
$11.4M497%N/A
#4
$12.8M50N/AN/A
#5
$12.3M504%N/A